-
Nov 1, 2025
Juliana M. Reed, executive director of the Biosimilars Forum, released the following statement following the FDA’s formal issuance of new draft guidance—accompanied...
-
Oct 30, 2025
Juliana M. Reed, executive director of the Biosimilars Forum, released the following statement following the FDA’s formal issuance of new draft guidance—accompanied...
-
Apr 30, 2025
America’s skyrocketing prescription drug costs must be addressed. President Trump, U.S. Food and Drug Administration (FDA) Commissioner Marty Makary, and other...
Nov 1, 2025Juliana M. Reed, executive director of the Biosimilars Forum, released the following statement following the FDA’s formal issuance of new draft guidance—accompanied...